Compelling Content for Pharma-Biotech-Healthcare sectors
Healthcare innovators are constantly looking for ways to make the system more efficient and affordable. A rapidly evolving field, the blockchain technology has created quite a rage and the disruptive technology is all set to transform the healthcare sector.
Motor dysfunction and muscle weakness constitute the major symptoms of MS; however many MS patients also struggle with heat intolerance.
Ion channels are membrane proteins, which play a principal role in regulating cellular excitability. They are found in virtually all cells, and are of crucial physiological importance.
Prebiotics have emerged as an effective nonpharmacological approach to re-establish gut symbiosis and promote well being.
Prebiotics are considered to be functional foods in that they provide numerous health benefits and aid in the prevention and treatment of diseases and health conditions.
Cardiovascular disease (CVD) has emerged as one of the major cause of mortality worldwide and contributes significantly to rising healthcare cost. Commonly presumed to be “male” disease, CVD is one of the leading causes of mortality in women, especially postmenopausal.
Virtual clinical trials have come out to be a concept which can speed up the drug development timeline and at the same time, take some of the costs out of the whole process. Virtual trials utilize novel technologies like monitoring devices, various apps, and the social media to conduct various stages of the trial.
Gene therapy represents a major shift in medicine. It involves the use of a vector, for example, a modified virus, to insert corrected gene into human cells to correct a mutated gene. Gene therapy aims to correct the underlying genetic cause of a disease and not just the disease symptoms and this, has led to a new ray of hope for patients with rare disease and cancer sufferers.
Over the past decade, significant advancements have been made in the field of medical sciences. Discovery of new therapeutic classes and development of novel technologies have led to better treatment strategies and improved quality of life for the patients. Microbiome therapeutics has emerged as a significant addition to the innovations in medical science.
Rheumatoid arthritis (RA) is a debilitating disease with a worldwide prevalence of 1%. The autoimmune disorder currently has no cure and treatment strategy basically involves a trial and error approach, which ultimately increases the risk of disease progression. A recent study by Northwestern University Feinberg School of Medicine has demonstrated that genetic profiling of joint tissues can help to determine optimal therapy for RA patients and in turn avoid treatment delays and unnecessary adverse events.
Poly (ADP ribose) polymerase (PARP) inhibitors are novel anticancer agents that target the DNA damage response and DNA repair pathway. This exciting new class has emerged as an effective treatment strategy for BRCA-mutated ovarian cancers and metastatic breast.
NASH is a leading cause of liver-related morbidity and mortality worldwide and is poised to be the leading cause of liver transplants by 2020. Despite the enormous burden to global healthcare system and debilitating consequences for patients, there are currently no FDA approved pharmacological therapies specially catering to NASH. As a matter of fact, serious concerns have been generated to develop effective treatment strategies for NASH throughout the medical community.